Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late)
Condition(s) studied
Investigational drug(s) / intervention(s)
Mechanical Thrombectomy: Mechanical Thrombectomy: A stroke treatment method involving the use of a device to extract a blood clot from the blood vessels, restoring blood flow and reducing brain damage. Ischemic Post-conditioning: After thrombectomy, a procedure involving inflating and deflating a balloon in situ for four cycles of 2 minutes each, reducing reperfusion injury and minimizing neural damage. Selective Hypothermia: Administering cold saline either intra-arterially or within the cerebral sinus to lower brain temperature, mitigating ischemia-induced injury.
Study summary
The objective of this study is to create a comprehensive, multi-center, TRACK-LVO registry-linked cohort of consecutive patients with acute ischemic stroke (AIS) caused by large vessel occlusions (LVO) and presenting to each participating center beyond 24 hours from last known well, who are treated with either endovascular therapy (EVT) or the best available medical management (BMM).
Eligibility
Primary outcome measure(s)
- Modified ranking scale (mRS) at 90 days — 90 days
A 0-6 scale running from perfect health without symptoms to death. - symptomatic intracranial hemorrhage — 72 hours
any hemorrhagic transformation on subsequent imaging associated with a neurological decline of at least 4 points increase on the NIHSS score
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tianjin Huanhu Hospital | Tianjin | Tianjin Municipality | Recruiting |
More Tianjin Huanhu Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06200753 on ClinicalTrials.gov ↗ ← All trials in China